Back

HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in basic science 2 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Iryna Vyshnevska

L.T. Malaya Therapy National institute of NAMSU, Kharkiv (Ukraine)

7 More presentations in this session

Presentation thumbnail
DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic
Mr C. Geraeds (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction
Associate Professor I. Vyshnevska (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo
Doctor A. Raduly (Debrecen, HU)
Abstract Slides Video
Presentation thumbnail
MicroRNA-based network analysis identified the NOVA1 gene as a potential new target in end-stage heart failure
Miss T. Balint (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Novel insights in cardiac fibrosis in HFpEF: potential role of UBALD2-enriched endothelial extracellular vesicles
Miss B. Losada Fuentenebro (Pamplona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in basic science 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Predicting adverse cardiac remodeling after ST-elevation myocardial infarction with novel biomarkers soluble isoform of suppression tumorigenicity-2 and macrophage migration inhibitory factor
thumbnail
Congress Presentation
The role of left ventricular global longitudinal strain and myeloperoxidase in prognostication of major adverse clinical events for patients with ST elevation myocardial infarction and obesity
thumbnail
Congress Presentation
The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources